Affiliation
Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.Issue Date
1988-08
Metadata
Show full item recordCitation
Phase II study of TCNU in advanced breast cancer. 1988, 24 (8):1377-8 Eur J Cancer Clin OncolJournal
European Journal of Cancer & Clinical OncologyDOI
10.1016/0277-5379(88)90232-5PubMed ID
3181260Type
ArticleLanguage
enISSN
0277-5379ae974a485f413a2113503eed53cd6c53
10.1016/0277-5379(88)90232-5
Scopus Count
Collections
Related articles
- TCNU in advanced renal cancer. Phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
- Authors: Van Oosterom AT, Droz JP, Fossa ST, Bono AV, Splinter TA, Verbaeys AJ, Keizer J, De Pauw M, Sylvester R
- Issue date: 1989 Dec
- Randomized phase II trial of TCNU versus mitozolomide in malignant melanoma. EORTC Early Clinical Trials Group.
- Authors: Smyth JF, Gundersen S, Renard J, Pinedo HM
- Issue date: 1989 Apr
- A phase II trial of TCNU in patients with squamous, adeno and large cell carcinoma of the lung.
- Authors: Vibe-Petersen J, Bach F, Pedersen AG, Smyth J, Hansen HH
- Issue date: 1989 Dec
- Phase I study of TCNU, a novel nitrosourea.
- Authors: Smyth JF, Macpherson JS, Warrington PS, Kerr ME, Whelan JM, Cornbleet MA, Leonard RC
- Issue date: 1987 Dec
- Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer.
- Authors: Smyth JF, Hardcastle JD, Denton G, Alderson D, Grace RH, Mansi JL, Yosef HM, Nordle O, Lauri H, Wählby S
- Issue date: 1995 Nov